- Presentations
- 4
- Markets
- 1
Rytary is a brand of Carbidopa and Levodopa marketed by Amneal Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Carbidopa and Levodopa
- Brand owner
- Amneal Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 23.75 mg/95 mg extended-release capsule, 36.25 mg/145 mg extended-release capsule, 48.75 mg/195 mg extended-release capsule, 61.25 mg/245 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rytary 23.75 mg/95 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Rytary 36.25 mg/145 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Rytary 48.75 mg/195 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Rytary 61.25 mg/245 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Carbidopa and Levodopa.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rytary
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.